UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026275
Receipt number R000030040
Scientific Title Usefulness of 18F-NaF PET/CT for bone metastasis
Date of disclosure of the study information 2017/02/28
Last modified on 2020/03/13 08:41:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Usefulness of 18F-NaF PET/CT for bone metastasis

Acronym

18F-NaF for bone metastasis

Scientific Title

Usefulness of 18F-NaF PET/CT for bone metastasis

Scientific Title:Acronym

18F-NaF for bone metastasis

Region

Japan


Condition

Condition

bone metastasis

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To compare diagnostic efficiency and prediction of treatment for bone metastasis between 18F-NaF PET and conventional images includes bone scintigraphy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Effectiveness of 18F-NaF PET for determining of predicting the effect of bone metastasis treatment.

Key secondary outcomes

Effectiveness of 18F-NaF PET for detecting bone metastasis.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Medicine

Interventions/Control_1

Injection of PET tracer
One injection for one exam
Radiation dose is under 370 MBq for one exam

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Diagnosed as bone metastasis
2) Regardless of sex
3) informed consent is available

Key exclusion criteria

1) Who have already undergone radiotherapy or surgical treatment for bone metastasis
2) Poor condition (i.e. Performance status 3 or 4)
3) Those who is breastfeeding, pregnant or wish for pregnancy
4) Those who is thought to be inappropriate by researcher

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Akihiro
Middle name
Last name Nishie

Organization

Graduate School of Medical Science, Kyushu University

Division name

Department of Clinical Radiology

Zip code

812-8582

Address

3-1-1 Maidashi, Higashi-ku, Fukuka-shi, Fukuoka, Japan

TEL

092-641-1151

Email

anishie@radiol.med.kyushu-u.ac.jp


Public contact

Name of contact person

1st name Yoshiyuki
Middle name
Last name Kitamura

Organization

Graduate School of Medical Science, Kyushu University

Division name

Department of Clinical Radiology

Zip code

812-8582

Address

3-1-1 Maidashi, Higashi-ku, Fukuka-shi, Fukuoka, Japan

TEL

092-641-1151

Homepage URL


Email

ykita@radiol.med.kyushu-u.ac.jp


Sponsor or person

Institute

Department of Clinical Radiology, Graduate School of Medical Science, Kyushu University

Institute

Department

Personal name



Funding Source

Organization

Grant-in-Aid for Scientific Research

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyushu University research ethics committee

Address

3-1-1 Maidashi, Higashi-ku, Fukuka-shi, Fukuoka, Japan

Tel

092-642-5082

Email

byskenkyu@jimu.kyushu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 02 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

8

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2017 Year 02 Month 02 Day

Date of IRB

2017 Year 02 Month 02 Day

Anticipated trial start date

2017 Year 02 Month 28 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

under progress


Management information

Registered date

2017 Year 02 Month 23 Day

Last modified on

2020 Year 03 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030040


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name